Novel Zn(II) and Cd(II) complexes demonstrate unique structures and bonding interactions, highlighting their potential applications.
Two new Zn(II)/Cd(II) complexes, [Zn(L)(cba)] n ( 1 ) and [Cd(L)(Br) 2 ]·H 2 O ( 2 ) (L = 2-(4-fluoro-phenyl)-1H-imidazo[4,5-f][1,10]phenanthroline, H 2 cba = 4-Carboxyphenoxyacetic acid), have been synthesized hydrothermally and their structures and properties were systematically analyzed and characterized. 1 is composed of the [Zn(L)(cba)] unit, each deprotonated 4-cba 2- ligand chelates a Zn(II) atom, forming a 1D chain structure. The 1D double-chain structure is further formed through the π–π stacking interactions between L ligands. In addition, 2 is composed of the [Cd(L)(Br) 2 ] unit. The molecule is further extended into a 1D supramolecular chain via the interactions between nitrogen-containing ligands, and the 1D chain structure is further stabilized by hydrogen bonding interactions.
No takes yet. Share an insight, caveat, or question.
Chai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: